T-lymphoproliferative Disorder
📧 Sign up to get email alerts when something new happens for T-lymphoproliferative Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-05-03Clinical Trial Update: Alemtuzumab (Campath) to Treat T-Large Granular Lymphocyte Leukemia [Phase 2]
A Phase 2 clinical trial evaluated alemtuzumab (Campath) for T-LGL lymphoproliferative disorders and has completed with results posted.